作者

David Mulder

高级律师

Read More

Christian Dekoninck

合伙人

Read More

Adrian Toutoungi

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr. Angela Knierim

高级律师

Read More

Agnieszka Sztoldman

高级律师

Read More
作者

David Mulder

高级律师

Read More

Christian Dekoninck

合伙人

Read More

Adrian Toutoungi

合伙人

Read More

Dr. Anja Lunze, LL.M.

合伙人

Read More

Dr. Angela Knierim

高级律师

Read More

Agnieszka Sztoldman

高级律师

Read More

2020年11月23日

Pharmaceutical patent law – 2 / 2 观点

Pharmaceutical patent law in times of crisis: A comparative study – Part 2

  • Quick read

Which extraordinary regulations have been put in place for speeding up clinical trials in emergency situations like the current coronavirus pandemic? And how is early access to new medicines warranted under such circumstance?

The second part of the two-part series ‘Pharmaceutical Patent Law in Times of Crisis: A Comparative Study’, written for the European Intellectual Property Review by our international team, addresses these questions and more on both a broad, European level and from the perspective of six national jurisdictions.
 

Read the article here

Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

专利与创新

Pharmaceutical patent law in times of crisis: A comparative study – Part 1

2020年11月9日
Quick read

作者

点击此处了解更多
warsaw
酒店与休闲

CJEU ruling to liberalise parallel import in Poland

2020年8月25日
IN-DEPTH ANALYSIS

作者 Agnieszka Sztoldman

点击此处了解更多
pills
新冠病毒

Patent law in emergency situations

2020年7月14日
QUICK READ

作者 David Mulder

点击此处了解更多